| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 01/20/2005 | US20050014916 Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014800 Vision defects; anticancer agents; antitumor agents |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014765 Aryl-heteroaromatic products, compositions comprising them and use |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/20/2005 | US20050011744 Process for recovering caprolactam from aqueous caprolactam product using situ prepared alkali amino caproate |
| 01/20/2005 | US20050011019 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers |
| 01/20/2005 | CA2530538A1 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497267A2 Method for the production of chiral imidazolidin-2-ones |
| 01/19/2005 | EP1497260A1 Novel methoxybenzamide compounds for use in mch receptor related disorders |
| 01/19/2005 | EP1496893A2 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
| 01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| 01/19/2005 | CN1568316A Activator for peroxisome proliferator-responsive receptor delta |
| 01/19/2005 | CN1568298A Luminous compounds and labeling reagents using the same |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1566101A Process for producing optically active hemiesters |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566094A Antiviral activity possessed compound |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/18/2005 | US6844434 Synthesis of temozolomide and analogs |
| 01/18/2005 | US6844404 Catalyst compositions for the polymerization of olefins |
| 01/18/2005 | US6843256 Cationic imidazole dyes; storage stability |
| 01/13/2005 | WO2005003097A1 Cis-2,4,5-triaryl-imidazolines |
| 01/13/2005 | WO2005002575A1 Cis-imidazolines as mdm2 inhibitors |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | US20050009930 Carotenoid analogs or derivatives for controlling connexin 43 expression |
| 01/13/2005 | US20050009900 3-Substituted with a heterocyclic group, e.g., 2-Chloro-5-[1-(2,3-dihydroxy-propyl)-5-methyl-1H-pyrazol-3-yl]-N-(1-hydroxy-cycloheptylmethyl)-benzamide; treatment of IL-1 mediated disorders, including osteo- and rheumatoid arthritis, allergies, asthma, COPD, cancer, and reperfusion or ischemia in stroke |
| 01/13/2005 | US20050009834 E.g., 3-(2-chloro-6-fluorophenyl)-1-[4-(3,5-dichloropyridin-2-yloxymethyl)phenyl]-5-methyl-1H-1,2,4-triazole and 3-(3-chloropyridin-2-yl)-1-[4-(3-chloro-5-trifluoromethylpyridin-2-yloxymethyl)phenyl]-5-methyl-1H-1,2,4-triazole; for use as pesticides, especially insecticides and acaricides |
| 01/13/2005 | US20050009816 Potassium channel modulators |
| 01/13/2005 | US20050009791 Especially lysine, arginine, histidine, omithine and diaminobutyric acid; improved solubility for parenteral administration |
| 01/13/2005 | US20050009788 The analog includes a conjugated polyene with 7 to 14 double bonds and a 3,3-dimethylcyclohexenylene or 3,3-dimethylcyclohexen-6-onylene ring; especially for treating cardiac arrhythmia and cancerous and pre-cancerous cells |
| 01/13/2005 | US20050009758 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 01/13/2005 | US20050005840 Production of ionic liquids |
| 01/13/2005 | CA2528119A1 Cis-2,4,5-triaryl-imidazolines |
| 01/12/2005 | EP1495036A1 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates |
| 01/12/2005 | EP1495035A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof |
| 01/12/2005 | EP1494998A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP0893442B1 Lymph-absorbable imidazole derivatives |
| 01/12/2005 | CN1564813A Intermediate for biotin and process for producing the same |
| 01/12/2005 | CN1562977A Method for producing hydantoin of intermediate of sweeting agent |
| 01/12/2005 | CN1184248C Catalyst and method for trimerization of isocyanates |
| 01/12/2005 | CN1184199C Method for preparing methylthioamino acid or alkali salts thereof |
| 01/12/2005 | CN1184196C Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 01/12/2005 | CN1183907C Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same |
| 01/11/2005 | US6841696 N-unsubstituted amidinium salts |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841304 Dissolves other salts, in particular metallic salts, such as lithium salts, to give highly conductive solutions |
| 01/06/2005 | WO2005000821A1 Tachykinin receptor antagonists |
| 01/06/2005 | WO2005000800A1 Cathepsin cysteine protease inhibitors |
| 01/06/2005 | WO2005000798A1 Heterocyclic methyl sulfone derivative |
| 01/06/2005 | WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | WO2004101573A9 Synthesis of substituted heterocyclic compounds |
| 01/06/2005 | US20050004370 Biimidazole diamide anion binding agents |
| 01/06/2005 | US20050004369 Phenyl substituted carboxylic acids |
| 01/06/2005 | US20050004235 Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004198 Central nervous system, lipid metabolism and gall function disorders; ectoparasite infections; suppressing snoring |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004086 Indene derivatives as pharmaceutical agents |
| 01/06/2005 | US20050004082 Ether compounds |
| 01/06/2005 | US20050004043 Protease inhibitors; human t-cell leukemia virus; aids |
| 01/06/2005 | CA2556706A1 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | CA2530068A1 Cyanoalklamino derivatives useful as cathepsin cysteine protease inhibitors |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 01/05/2005 | EP1493734A1 Novel crystal form of 5-hydroxy-1-methylhydantoin |
| 01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
| 01/05/2005 | EP1492518A2 Tuberculosis treatment using pleuromutilin derivatives |
| 01/05/2005 | CN1561333A Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561326A Alpha-haloenamine reagents |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1183174C Use of cationic copolymers for unsaturated acids and N-vinylimidazolium salts in cosmetic hair formulations |
| 01/04/2005 | US6838476 Imidazoles with anti-inflammatory activity |
| 01/04/2005 | US6838475 For prophylaxis and therapy of one or more symptoms of hepatitis C |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/04/2005 | US6838415 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 01/04/2005 | CA2293834C Substituted naphthopyrans |
| 12/30/2004 | US20040267027 Reacting imidazole and triphenyl carbinol in solid phase under microwave energy; for production of bifonazole |
| 12/30/2004 | US20040267026 Treating N-acylated alpha -amino nitrile with triarylphosphine and a carbon tetrahalide to form haloimidazole; for production of losartan and angiotensin H antagonists |
| 12/30/2004 | US20040267017 3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors |
| 12/30/2004 | US20040266901 Novel photosensitive compound, photosensitive resin, and photosensitive composition |
| 12/30/2004 | US20040266830 Insulin sensitivity enhancer and second antidiabetic of different mechanism; suppressing hyperglycemia |
| 12/30/2004 | US20040266774 Amide compounds |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |